The impact of curative cancer treatment on sexual health - clinical results from the EORTC QLQ-SH22 validation study.

ABSTRACT:

Background

The European Organization of Research and Treatment of Cancer (EORTC) has recently developed and validated a patient-reported outcome measure (PROM) for sexual health (SH) in cancer patients. Here, we present results from a secondary analysis of the EORTC QLQ-SH22 validation study. The objective was to investigate the impact of cancer treatment on SH over the disease trajectory into survivorship in patients who underwent curative treatment.

Methods

Participants completed the EORTC QLQ-SH22 and the EORTC QLQ-C30 assessing SH and Quality of Life. We analyzed differences in SH of patients on active cancer treatment compared to patients off-treatment (cross sectional group comparison) as well as changes in SH during the course of treatment (from pre-treatment to follo

SUBMITTER: Oberguggenberger AS 

PROVIDER: S-EPMC11552421 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature